Azactam Injection, Powder, For Solution
Product Images NDC 0003-2560

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azactam (NDC 0003-2560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azactam 1gram Vial Label (Azactam 1g Vial Lbl)

Label for AZACTAM 1 gram injection powder for solution, containing aztreonam. The label indicates it is for IV or IM use after constitution and is single-dose vial. It is manufactured by Bristol-Myers Squibb Company, with storage instructions to avoid excessive heat. The label includes an NDC barcode and spaces for lot and expiration dates.*

FDA Label Image

Aztreonam 2 Gram Vial Label (Azactam 2g Vial Lbl)

The label for AZACTAM (aztreonam for injection, USP) 2 grams powder for solution injection. It is a sterile product for intravenous or intramuscular use, packaged in a single vial. The label includes usage instructions, storage conditions to keep the vial dry and at room temperature, and the manufacturer information, Bristol-Myers Squibb Company. The NDC code 0003-2570-16 and barcodes are also visible, as well as placeholders for lot number and expiration date.*

FDA Label Image

Aztreonam Chemical Structure (Aztreonam Struct)

Chemical structure diagram depicting the molecular structure of aztreonam, the active ingredient in AZACTAM injection, powder for solution by E.R. Squibb & Sons, L.L.C.*

FDA Label Image

Figure 1 (Figure 1)

A line graph depicting Aztreonam serum concentration (mcg/mL) over time in hours. The graph includes curves for different dosages and administration routes: 2 g IV, 1 g IV, 1 g IM, and 500 mg IV/IM, showing serum concentration decreases from 0 to 8 hours post-dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.